Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer

Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer

FromASCO Education


Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer

FromASCO Education

ratings:
Length:
5 minutes
Released:
May 30, 2018
Format:
Podcast episode

Description

Dr. Linh Alejandro, a clinical oncology pharmacist at the University of California, San Diego Health Systems discusses the approval of olaparib for germline BRCA-mutated metastatic breast cancer.
Released:
May 30, 2018
Format:
Podcast episode

Titles in the series (100)

The ASCO Education Podcast features expert conversations on the most talked-about topics in oncology today from physician burnout, medical cannabis, COVID and cancer and more…